U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA498216 ID: 498216

A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma

Guenther LM, Dharia NV, Ross L, Conway AS, Robichaud AL, Catlett JL, Wechsler C, Frank ES, Goodale AB, Church AJ, Tseng Y-Y, Guha R, McKnight CG, Janeway KA, Boehm JS, Mora J, Davis MI, Alexe G, Piccioni F, Stegmaier K. More...
AccessionPRJNA498216
Data TypeRaw sequence reads
ScopeMultispecies
Grants
  • "Inhibition of CDK4 and IGF-1R in Ewing Sarcoma - Harnessing Chemical and Genomic Screening for Therapeutic Benefit in Ewing Sarcoma" (Grant ID L40 CA220943, National Cancer Institute)
  • "Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics" (Grant ID R01 CA204915, National Cancer Institute)
  • "Research Training in Pediatric Oncology" (Grant ID T32 CA136432, National Cancer Institute)
SubmissionRegistration date: 24-Oct-2018
Dana-Farber Cancer Institute
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments2
Other datasets
BioSample2
SRA Data Details
ParameterValue
Data volume, Gbases17
Data volume, Mbytes8366

Supplemental Content

Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Support Center